Current Report Filing (8-k)

false 0001496454 0001496454 2022-07-22 2022-07-22

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): July 22, 2022

 

 

CNL Healthcare Properties, Inc.

(Exact Name of Registrant as Specified in its Charter)

 

 

 

Maryland		000-54685		27-2876363
(State or Other Jurisdiction of Incorporation)		(Commission File Number)		(IRS Employer Identification No.)

450 South Orange Ave.

Orlando, Florida 32801

(Address of Principal Executive Offices; Zip Code)

Registrant’s telephone number, including area code: [phone]

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐	Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
None		N/A		N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

---

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(c)     Following the previously announced resignation of John F. Starr as the chief operating officer and senior vice president of CNL Healthcare Properties, Inc. (the “Company”), the Company has reorganized certain of Mr. Starr’s former job responsibilities as chief operating officer. As previously announced in the Company’s Current Report on Form 8-K dated June 29, 2022, effective July 22, 2022, John R. McRae, chief investment officer of the Company’s advisor, CNL Healthcare Corp. (the “Advisor”), will be named senior vice president of the Company assuming Mr. Starr’s oversight and executive leadership role with respect to the Company’s asset management functions and Ixchell C. Duarte, the Company’s chief financial officer and treasurer, will additionally assume Mr. Starr’s oversight and executive leadership role with respect to the Company’s financial planning and analysis and portfolio reporting functions. However, Michael Tetrick, Senior Vice President and Investment Risk Officer at CNL, will no longer be named senior vice president of the Company and will not be assuming any of Mr. Starr’s functions of chief operating officer.

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 22, 2022						CNL HEALTHCARE PROPERTIES, INC.
						a Maryland corporation
				By:		/s/ Stephen H. Mauldin
						Stephen H. Mauldin
						Chief Executive Officer and President